Bharat Parenterals, a company in the Pharmaceuticals industry, reported revenue of ₹136 crore and net profit of ₹12 crore for the September 2026 quarter.
Bharat Parenterals (NSE: BPLPHARMA) closed at ₹2,312.00 on 20 Nov 2026. Its market capitalisation is ₹1,593 crore and it trades at 1285.0 times earnings.
Incorporated in 1992, Bharat Parenterals Ltd is in the business of manufacturing and marketing of formulations
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.